Zydus receives final approval from the USFDA for Baclofen Tablets

Zydus Cadila has received the final approval from the USFDA to market Baclofen Tablets (US RLD- Lioresal), 10 mg and 20 mg. It will be manufactured at the group's formulations manufacturing facility at Baddi. Baclofen is used to treat muscle spasms caused by certain conditions such as multiple sclerosis, spinal cord injury/disease. It works by helping to relax the muscles.

Powered by Capital Market - Live News